Senti Biosciences (SNTI) Other Operating Expenses (2021 - 2025)

Senti Biosciences has reported Other Operating Expenses for 4 years, with the latest figure at $5.1 million in Q4 2025.

• For the quarter ending Q4 2025, Other Operating Expenses rose 1514.06% year-over-year to $5.1 million; the trailing twelve-month figure through Dec 2025 stood at $5.1 million (up 1514.06% YoY), and the FY2025 full-year result was $5.1 million, up 1514.06% from the prior year.
• Other Operating Expenses for Q4 2025 stood at $5.1 million, up from $313000.0 in the prior quarter.
• The five-year high for Other Operating Expenses was $25.7 million in Q3 2023, with the low at $1178.0 in Q1 2021.
• Average Other Operating Expenses over 4 years is $6.3 million, with a median of $313000.0 recorded in 2024.
• Year-over-year, Other Operating Expenses grew 15.5% in 2024 and jumped 1514.06% in 2025.
• Tracing SNTI's Other Operating Expenses over 4 years: stood at $1178.0 in 2021, then jumped by 22905.09% to $271000.0 in 2023, then rose by 15.5% to $313000.0 in 2024, then soared by 1514.06% to $5.1 million in 2025.
• The last three Other Operating Expenses figures came in at $5.1 million (Q4 2025), $313000.0 (Q4 2024), and $271000.0 (Q4 2023), per Business Quant data.

Peer Comparison